Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioPortfolio's Approved Drugs Database

Amlexanox

Amlexanox

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Press Releases About Amlexanox:

 BioPortfolio Logo
ULURU Inc. Announces Signing of European Agreement With Meda AB for the Marketing of Amlexanox 5 Percent Paste and OraDisc(TM) A 17th November, 2008 ULURU Inc.
ADDISON, Texas, Nov. 17 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) today announced the signing of a License Agreement with Meda AB (Meda) to market Amlexanox 5% paste and OraDisc(TM) A

This page has been viewed 26 times Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Amlexanox across BioPortfolio, or for Amlexanox Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.